Where does Respire Medical Holdings LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Respire Medical Holdings LLC ranks #33,060 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Respire Medical Holdings LLC hold?

Respire Medical Holdings LLC holds 8 US utility patents granted between 2016 and 2023, spanning 2 technology areas.

What is Respire Medical Holdings LLC's Innovation Score?

Respire Medical Holdings LLC has an Innovation Score of 20.7 out of 100 (7th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Respire Medical Holdings LLC focus on?

Respire Medical Holdings LLC's top technology area is A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene) with 1 patents, ranking #388 of 546 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Respire Medical Holdings LLC's patent grant rate increasing or decreasing?

Respire Medical Holdings LLC's recent grant velocity is -86% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Respire Medical Holdings LLC's patents?

Respire Medical Holdings LLC's patents average 2.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Respire Medical Holdings LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Respire Medical Holdings LLC

USPTO PatentsView assignee record - 8 granted patents across 2 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Respire ranks #33,060 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 2 technology areas.

#33,060
of 49,997 US assignees by volume: 7th percentile
by Innovation Score (20.7/100): 2.4
avg claims per patent: -86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33060 · US Corporation #33,060 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #33,060/49,997
PHOTO-FINISH Remis Gesellschaft…
CPC-NARROW A61C · 2 areas
INNOV-THIN 20.7/100
CLAIMS-SPARSE 2.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -86% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Remis Gesellschaft Fuer Entwicklung UND Vertrieb VON Technischen Elementen MBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Respire’s 20.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (37%) Velocity 6.7 pts (32%) Breadth 5.0 pts (24%) Claim depth 1.4 pts (7%)

Qualcomm Incorporated · highest

85
Respire Medical… · this assignee

21
3D Lighting… · lowest

7

What this shows Respire's Innovation Score is 20.7/100 (7th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Respire?

Each dot is one of Respire’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Respire’s own 2.4 claims/patent is at or below the 14.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Respire vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Respire's grants concentrate

Respire Medical Holdings LLC is a focused PatentsView assignee: 2 CPC subclasses with 12.5% of grants classified under A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2023. By volume, Respire sits between Remis Gesellschaft Fuer Entwicklung UND Vertrieb VON Technischen Elementen MBH and Rfaxis, Inc..

Respire's three-year grant acceleration

Respire Medical Holdings LLC shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Remis Gesellschaf…

8
Remo

8
Renescience A/S

8
Resilux

8
Retinal Solutions

8
REV Robotics

8
RF Venue

8
Rfaxis

8
Respire Medical H… ◀

8

What this shows Respire holds 8 patents at rank #33,009, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Respire

By rank, the assignees closest to #33,009 in granted patent volume.

Leaders in A61C (Dentistry)

Other assignees with the most granted patents in Respire's primary technology class.

Respire's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 7th percentile higher than 7% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Respire Medical Holdings LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	5	62.5%
2017	2	25.0%
2023	1	12.5%

Which technologies does Respire Medical Holdings LLC patent most?

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Respire Medical Holdings LLC's patent record in context - here's where to go next.

Respire Medical Holdings LLC's lead technology class is A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene), 12.5% of its portfolio - see every assignee active in that class. Explore A61C
Ranked #33,060 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Respire Medical Holdings LLC against Remis Gesellschaft Fuer Entwicklung UND Vertrieb VON Technischen Elementen MBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 20.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.